Life Science REIT (LON:LABS) Stock Price Down 4.9% – Time to Sell?

Life Science REIT plc (LON:LABS)’s stock price traded down 4.9% on Monday . The stock traded as low as GBX 39 ($0.49) and last traded at GBX 39 ($0.49). 583,238 shares traded hands during trading, a decline of 43% from the average session volume of 1,031,143 shares. The stock had previously closed at GBX 41 ($0.52).

Analyst Ratings Changes

A number of research firms have recently issued reports on LABS. Jefferies Financial Group reduced their price target on shares of Life Science REIT from GBX 45 ($0.57) to GBX 36 ($0.46) and set a “hold” rating for the company in a research report on Friday, August 30th. Shore Capital restated a “buy” rating on shares of Life Science REIT in a research note on Thursday, September 26th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 57 ($0.72) price target on shares of Life Science REIT in a research note on Thursday, October 3rd.

Life Science REIT Stock Down 4.9 %

The business’s fifty day moving average is GBX 38.37 and its two-hundred day moving average is GBX 36.13. The firm has a market cap of £136.50 million, a price-to-earnings ratio of -650.00 and a beta of 0.08.

Life Science REIT Announces Dividend

The firm also recently announced a dividend, which was paid on Thursday, October 31st. Stockholders of record on Thursday, October 3rd were paid a GBX 1 ($0.01) dividend. This represents a dividend yield of 3.11%. The ex-dividend date was Thursday, October 3rd. Life Science REIT’s dividend payout ratio (DPR) is presently -3,333.33%.

Life Science REIT Company Profile

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.